Key result
Serum adiponectin levels were decreased in patients with diabetic retinopathy but increased in those with diabetic nephropathy compared to healthy controls.
Cross-Sectional (n=75)
No
Serum adiponectin levels are decreased in diabetic retinopathy but increased in diabetic nephropathy, suggesting it may serve as a prognostic marker for specific microvascular complications in type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Adiponectin may differentiate diabetic microvascular complications; hypothesis-generating and should not yet change practice.
This study aimed to elucidate the role of adiponectin in evolution of microvascular complication of type 2 diabetes mellitus, in particular retinopathy and nephropathy. In addition, we attempted to find a correlation between the serum levels of adiponectin and different parameters such as duration of diabetes, age, sex, glycemic state, insulin resistance, lipid profile and albumin-creatinine ratio in type 2 diabetic patients with retinopathy and nephropathy in order to understand more about these risk factors . This study involved sixty diabetic patients with type 2 diabetes mellitus with or without micro vascular complications involving either retinal or renal vasculatures or both. These patients were recruited from the outpatient clinic (A written consent was obtained from each case included in the study according to the Ethical Committee Approval of the Research Institute of Ophthalmology (RIO), Giza, Egypt. In addition to fifteen healthy subjects were involved and served as reference group. In addition to serum levels of adiponectin, routine diabetic diagnostic markers such as blood glucose levels, glycosylated Hb, insulin resistance, lipid profile, and kidney function tests were performed to all individuals included in the study. Full ophthalmological assessment including Fundus Fluorescein Angiography and clinical examinations (blood pressure, search for lower limb oedema, pallor, renal mass, etc.) have done for each subject. Data of this study revealed that the levels of serum adiponectin were decreased in patients with diabetic retinopathy while they were increased in patients with either diabetic nephropathy alone and to a lesser extent, in diabetic patients with nephropathy and retinopathy. Serum adiponectin levels were found to be correlated with some parameters of lipid profile in patients with mixed conditions, a notion that highlight the role of adiponectin in the pathogenesis of microvascular complications of diabetes. Moreover, these results suggest that increased total serum adiponectin may predict coexistence of vascular endothelial dysfunction in diabetic nephropathy patients. Therefore, we recommended that adiponectin can be used as a prognostic marker for diabetic complications which will initiate a new era for the management of diabetes.
No takes yet. Share an insight, caveat, or question.
Soher A. Mohammed Ismail (2016) conducted a cross-sectional in Type 2 diabetes mellitus (n=75). Diabetic microvascular complications (retinopathy and nephropathy) vs. Healthy controls and uncomplicated type 2 diabetes was evaluated on Serum adiponectin concentration. Serum adiponectin levels were decreased in patients with diabetic retinopathy but increased in those with diabetic nephropathy compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: